
|Articles|March 13, 2018
Certara Launches Quantitative Systems Pharmacology Consortium on Immuno-oncology
Advertisement
Certara announced the launch of its Quantitative Systems Pharmacology (QSP) Immuno-oncology Simulator Consortium. This new QSP brings together biopharmaceutical companies to create a simulator that can model clinical populations of cancer patients in order to improve the development of immuno-oncology therapies.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Applied Clinical Trials' 2025 State of the Industry Survey
2
Do Phase II Protocol Learnings Help Simplify Phase III Protocol Designs?
3
The Confidence Trap in Clinical Trials: When Knowing Just Enough Becomes Dangerous
4
ACT Brief Weekly Recap: Clinical Research Faces Funding Strain, Data Evolution, and a Shift in Outsourcing Models
5